Holly May
Corporate Officer/Principal at BIOLINERX LTD.
Net worth: - $ as of 2024-04-29
Profile
Holly W.
May is currently the President-BioLineRx USA at BioLineRx Ltd.
She previously worked as the Vice President-Sales & Marketing at Swedish Orphan Biovitrum AB from 2018 to 2019.
Before that, she held positions as the Chief Commercial Officer at Avrobio, Inc., Vice President & Head-Commercial at Sobi, Inc., Vice President at Genzyme Israel Ltd., and Head-Marketing Operations at Sanofi-Aventis Israël Ltd.
Ms. May holds an MBA from the University of Akron and an undergraduate degree from the University of Miami.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOLINERX LTD.
-.--% | 2024-03-14 | 0 ( -.--% ) | - $ | 2024-04-29 |
Holly May active positions
| Companies | Position | Start |
|---|---|---|
| BIOLINERX LTD. | Corporate Officer/Principal | 2022-06-15 |
Former positions of Holly May
| Companies | Position | End |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Sales & Marketing | 2019-07-31 |
| Sanofi-Aventis Israël Ltd. | Sales & Marketing | - |
| Genzyme Israel Ltd. | Corporate Officer/Principal | - |
| Sobi, Inc. | Corporate Officer/Principal | - |
| AVROBIO, INC. | Corporate Officer/Principal | - |
Training of Holly May
| University of Akron | Masters Business Admin |
| University of Miami | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BIOLINERX LTD. | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| AVROBIO, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Sanofi-Aventis Israël Ltd. | |
| Sobi, Inc. | |
| Genzyme Israel Ltd. |
- Stock Market
- Insiders
- Holly May
